Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | HPGD | P15428 | 4/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | XDH | P47989 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL917251 | 0.89 | ALDH1A1 (0.34) | LMNAALDH1A1SMN1; SMN2P2RX7POLB | |
| SCHEMBL916264 | 0.88 | ALDH1A1 (0.34) | LMNAALDH1A1SMN1; SMN2P2RX7POLB | |
| SCHEMBL915366 | 0.87 | ALDH1A1 (0.36) | LMNAALDH1A1SMN1; SMN2P2RX7POLB | |
| SCHEMBL709121 | 0.83 | P2RX7 (0.44) | LMNAALDH1A1SMN1; SMN2GAAP2RX7 | |
| SCHEMBL5498286 | 0.83 | PGR (0.43) | P2RX7XDHIMPDH2 | |
| SCHEMBL917610 | 0.82 | LMNA (0.36) | LMNAALDH1A1SMN1; SMN2GAAP2RX7 | |
| SCHEMBL916474 | 0.81 | IMPDH2 (0.40) | LMNAALDH1A1POLBHPGDXDH | |
| SCHEMBL916794 | 0.80 | CYP1A2 (0.41) | LMNAALDH1A1SMN1; SMN2P2RX7POLB | |
| SCHEMBL917250 | 0.78 | ALDH1A1 (0.37) | ALDH1A1SMN1; SMN2GAAPOLBCYP1A2 | |
| SCHEMBL916806 | 0.74 | MAPT (0.35) | LMNAALDH1A1SMN1; SMN2GAAP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110009428-A1 | NOVEL ANDROGENS | N.V. ORGANON (NL) | 2011-01-13 | — | — | US | disclosed |
| EP-1742912-B1 | NOVEL ANDROGENS | ORGANON NV (NL) | 2010-08-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110009428-A1 | NOVEL ANDROGENS | NR5A1, AR, NR3C2 | LMNA 2915/4885ALDH1A1 2340/4885SMN1; SMN2 3754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.